Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Everus Construction Group (NYSE: ECG) closed at $37.97 in the last session, down -4.07% from day before closing price of $39.58. In other words, the price has decreased by -$4.07 from its previous closing price. On the day, 0.57 million shares were traded. ECG stock price reached its highest trading level at $39.38 during the session, while it also had its lowest trading level at $37.1978.
Ratios:
We take a closer look at ECG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $70.
On November 15, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $71.Stifel initiated its Buy rating on November 15, 2024, with a $71 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 25 ’25 when Marcy Maximillian J bought 1,300 shares for $38.99 per share. The transaction valued at 50,694 led to the insider holds 5,508 shares of the business.
Ryan Edward A bought 1,400 shares of ECG for $53,235 on Feb 25 ’25. The Director now owns 14,928 shares after completing the transaction at $38.02 per share. On Feb 18 ’25, another insider, DELLA ROCCA MICHAEL, who serves as the Director of the company, bought 1,050 shares for $47.56 each. As a result, the insider paid 49,943 and bolstered with 2,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ECG now has a Market Capitalization of 1936439680 and an Enterprise Value of 1990764032. As of this moment, Everus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.50, and their Forward P/E ratio for the next fiscal year is 13.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 4.58. Its current Enterprise Value per Revenue stands at 0.699 whereas that against EBITDA is 9.252.
Stock Price History:
Over the past 52 weeks, ECG has reached a high of $77.93, while it has fallen to a 52-week low of $31.38. The 50-Day Moving Average of the stock is -16.40%, while the 200-Day Moving Average is calculated to be -32.47%.
Shares Statistics:
According to the various share statistics, ECG traded on average about 792.52K shares per day over the past 3-months and 872900 shares per day over the past 10 days. A total of 50.98M shares are outstanding, with a floating share count of 50.76M. Insiders hold about 0.47% of the company’s shares, while institutions hold 73.08% stake in the company. Shares short for ECG as of 1741910400 were 1291626 with a Short Ratio of 2.46, compared to 1739491200 on 947873.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
